Mark Greene

Mark I.
Greene is the founder of Martell Diagnostic Laboratories, Inc., Hangzhou Saidekang Biotechnology Co., Ltd. Current jobs include Trustee at The Nightingale-Bamford School, Inc., Professor at Perelman School of Medicine since 1989, and Member of the Scientific Advisory Board at Macrophage Therapeutics, Inc. Former jobs include Chairman at The Allen-Stevenson School, Director-Emeritus at Emisphere Technologies, Inc., Independent Director at Navidea Biopharmaceuticals, Inc. from 2016 to 2018, Director at Ribi ImmunoChem Research, Inc., Associate Director at Abramson Cancer Center from 1987 to 2009, and Associate Professor at both Harvard University and Harvard Medical School from 1980 to 1986.
Education includes doctorates conferred in 1972 and 1977 from the University of Manitoba.